Metabolic intervention on lipid synthesis converging pathways abrogates prostate cancer growth

Oncogene

Volumn 32, Issue 42, 2013, Pages 5101-5110

  Fritz, V ^a,b,c   Benfodda, Z ^c,d   Henriquet, C ^e   Hure, S ^a,b,c   Cristol, J P ^f,g   Michel, F ^f,g   Carbonneau, M A ^g   Casas, F ^h   Fajas, L ^a,b,c,i,j  

^a INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^b CNRS   (France)

^c UNIVERSITÉ DE MONTPELLIER   (France)

^d Service de Médecine Physique et de Réadaptation   (France)

^e INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

^f LAPEYRONIE HOSPITAL   (France)

^g University Montpellier 1 et 2   (France)

^h CEMAGREF   (France)

ⁱ MONTPELLIER UNIVERSITY HOSPITAL   (France)

^j UNIVERSITY OF LAUSANNE   (Switzerland)

more..

Author keywords

Cancer; FAS; Lipids; Metabolism; Prostate

Indexed keywords

CASPASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MALONYL COENZYME A; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ARTICLE; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CELL METABOLISM; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIPOGENESIS; MALE; METABOLISM; NUCLEAR REPROGRAMMING; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CANCER;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; ENZYME INHIBITORS; FATTY ACID SYNTHASE, TYPE I; HUMANS; MALE; MALONYL COENZYME A; MICE, NUDE; MOLECULAR TARGETED THERAPY; NADP; NADPH OXIDASE; OXIDATIVE STRESS; PROSTATIC NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84886100124     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.523     Document Type: Article

References (22)

1. Kuhajda FP. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 2000; 16: 202-208. (Pubitemid 30114274)
2. Brusselmans K, Vrolix R, Verhoeven G, Swinnen JV. Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity. J Biol Chem 2005; 280: 5636-5645. (Pubitemid 40280043)
3. Brusselmans K, De Schrijver E, Verhoeven G, Swinnen JV. RNA interferencemediated silencing of the acetyl-CoA-carboxylase-alpha gene induces growth inhibition and apoptosis of prostate cancer cells. Cancer Res 2005; 65: 6719-6725. (Pubitemid 41060709)
4. Fritz V, Benfodda Z, Rodier G, Henriquet C, Iborra F, Avances C et al. Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice. Mol Cancer Ther 2010; 9: 1740-1754.
5. Fritz V, Fajas L. Metabolism and proliferation share common regulatory pathways in cancer cells. Oncogene 2010; 29: 4369-4377.
6. Pizer ES, Thupari J, Han WF, Pinn ML, Chrest FJ, Frehywot GL et al. Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. Cancer Res 2000; 60: 213-218. (Pubitemid 30070736)
7. Thupari JN, Pinn ML, Kuhajda FP. Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity. Biochem Biophys Res Commun 2001; 285: 217-223. (Pubitemid 32918056)
8. Kuhajda FP, Jenner K, Wood FD, Hennigar RA, Jacobs LB, Dick JD et al. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci USA 1994; 91: 6379-6383. (Pubitemid 24200664)
9. Swinnen JV, Brusselmans K, Verhoeven G. Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care 2006; 9: 358-365. (Pubitemid 44101970)
10. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007; 7: 763-777. (Pubitemid 47469806)
11. Menendez JA, Ropero S, Mehmi I, Atlas E, Colomer R, Lupu R. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis. Int J Oncol 2004; 24: 1369-1383.
12. Korczynska J, Stelmanska E, Nogalska A, Szolkiewicz M, Goyke E, Swierczynski J et al. Upregulation of lipogenic enzymes genes expression in white adipose tissue of rats with chronic renal failure is associated with higher level of sterol regulatory element binding protein-1. Metabolism 2004; 53: 1060-1065. (Pubitemid 38988294)
13. Stelmanska E, Korczynska J, Swierczynski J. Tissue-specific effect of refeeding after short- and long-term caloric restriction on malic enzyme gene expression in rat tissues. Acta Biochim Pol 2004; 51: 805-814. (Pubitemid 39296932)
14. Huang P, Feng L, EA Oldham, MJ Keating, W Plunkett. Superoxide dismutase as a target for the selective killing of cancer cells. Nature 2000; 407: 390-395.
15. Fogarty S, Hardie DG. Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim Biophys Acta 2010; 1804: 581-591.
16. Kato K, Ogura T, Kishimoto A, Minegishi Y, Nakajima N, Miyazaki M et al. Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation. Oncogene 2002; 21: 6082-6090.
17. Viollet B, Horman S, Leclerc J, Lantier L, Foretz M, Billaud M et al. AMPK inhibition in health and disease. Crit Rev Biochem Mol Biol 2010; 45: 276-295.
18. Zhang J, Bowden GT. UVB irradiation regulates Cox-2 mRNA stability through AMPK and HuR in human keratinocytes. Mol Carcinogen 2008; 47: 974-983.
19. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226: 497-509.
20. Sarruf DA, Iankova I, Abella A, Assou S, Miard S, Fajas L. Cyclin D3 promotes adipogenesis through activation of peroxisome proliferator-activated receptor gamma. Mol Cell Biol 2005; 25: 9985-9995. (Pubitemid 41572745)
21. Geer BW, Krochko D, Williamson JH. Ontogeny, cell distribution, and the physiological role of NADP-malic enxyme in Drosophila melanogaster. Biochem Genet 1979; 17: 867-879. (Pubitemid 10128591)
22. Eid AA, Ford BM, Block K, Kasinath BS, Gorin Y, Ghosh-Choudhury G et al. AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes. J Biol Chem 2010; 285: 37503-37512.